Sharon Longhurst
Directeur/Membre du Conseil chez IDOGEN AB (PUBL)
Postes actifs de Sharon Longhurst
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IDOGEN AB (PUBL) | Directeur/Membre du Conseil | 12/05/2020 | - |
| Independent Dir/Board Member | 12/05/2020 | - | |
| ELICERA THERAPEUTICS AB | Directeur/Membre du Conseil | 01/01/2024 | - |
| Independent Dir/Board Member | 01/01/2024 | - |
Historique de carrière de Sharon Longhurst
Anciens postes connus de Sharon Longhurst
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Corporate Officer/Principal | 01/10/2021 | 01/08/2023 |
| MENDUS AB | Corporate Officer/Principal | - | - |
Formation de Sharon Longhurst
| University of Warwick | Doctorate Degree |
| University of Surrey | Undergraduate Degree |
Statistiques
Internationale
| Suède | 4 |
| Royaume-Uni | 3 |
| Pays-Bas | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| IDOGEN AB (PUBL) | Health Technology |
| MENDUS AB | Health Technology |
| ELICERA THERAPEUTICS AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Gadeta BV
Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Health Technology |
- Bourse
- Insiders
- Sharon Longhurst
- Expérience
